Welcome to LookChem.com Sign In|Join Free

CAS

  • or
methyl 5-(4-(trifluoromethyl)phenyl)pyridine-3-carboxylate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

893734-81-1

Post Buying Request

893734-81-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

893734-81-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 893734-81-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,3,7,3 and 4 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 893734-81:
(8*8)+(7*9)+(6*3)+(5*7)+(4*3)+(3*4)+(2*8)+(1*1)=221
221 % 10 = 1
So 893734-81-1 is a valid CAS Registry Number.

893734-81-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 5-[4-(trifluoromethyl)phenyl]pyridine-3-carboxylate

1.2 Other means of identification

Product number -
Other names Methyl 5-(4-(trifluoromethyl)phenyl)nicotinate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:893734-81-1 SDS

893734-81-1Relevant articles and documents

Substituted piperidines as Par-1 Antagonists

-

Page/Page column 33, (2012/03/10)

The invention relates to novel substituted piperidines, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in parti

Substituted 3-(1,2,4-Oxadiazol-5-yl)-5-Phenylpiperidines

-

Page/Page column 16, (2012/06/01)

The invention relates to novel substituted piperidines, to processes for preparation thereof, to the use thereof for treatment and/or prophylaxis of diseases and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases

Substituted piperidines

-

Page/Page column 13; 14, (2012/06/16)

The invention relates to novel substituted piperidines, to processes for preparation thereof, to the use thereof for treatment and/or prophylaxis of diseases and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially of cardiovascular disorders and tumour disorders.

Substituted piperidines

-

Page/Page column 18; 21, (2012/06/18)

The invention relates to novel substituted piperidines, to processes for preparation thereof, to the use thereof for treatment and/or prophylaxis of diseases and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially of cardiovascular disorders and tumour disorders.

SUBSTITUTED PIPERIDINES

-

Page/Page column 17; 18, (2011/02/18)

The invention relates to novel substituted piperidines, to processes for preparation thereof, to the use thereof for treatment and/or prophylaxis of diseases and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially of cardiovascular disorders and tumour disorders.

SUBSTITUTED PIPERIDINES

-

Page/Page column 16, (2010/12/29)

The invention relates to novel substituted piperidines, to processes for preparation thereof, to the use thereof for treatment and/or prophylaxis of diseases and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially of cardiovascular diseases and tumour diseases.

Phenylpyridine derivatives

-

Page/Page column 23, (2010/11/25)

The present invention relates to the compounds of formula I: their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing such compoun

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 893734-81-1